1
|
Miraglia F, Pappalettera C, Barbati SA, Podda MV, Grassi C, Rossini PM, Vecchio F. Brain complexity in stroke recovery after bihemispheric transcranial direct current stimulation in mice. Brain Commun 2024; 6:fcae137. [PMID: 38741663 PMCID: PMC11089417 DOI: 10.1093/braincomms/fcae137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Revised: 12/22/2023] [Accepted: 05/07/2024] [Indexed: 05/16/2024] Open
Abstract
Stroke is one of the leading causes of disability worldwide. There are many different rehabilitation approaches aimed at improving clinical outcomes for stroke survivors. One of the latest therapeutic techniques is the non-invasive brain stimulation. Among non-invasive brain stimulation, transcranial direct current stimulation has shown promising results in enhancing motor and cognitive recovery both in animal models of stroke and stroke survivors. In this framework, one of the most innovative methods is the bihemispheric transcranial direct current stimulation that simultaneously increases excitability in one hemisphere and decreases excitability in the contralateral one. As bihemispheric transcranial direct current stimulation can create a more balanced modulation of brain activity, this approach may be particularly useful in counteracting imbalanced brain activity, such as in stroke. Given these premises, the aim of the current study has been to explore the recovery after stroke in mice that underwent a bihemispheric transcranial direct current stimulation treatment, by recording their electric brain activity with local field potential and by measuring behavioural outcomes of Grip Strength test. An innovative parameter that explores the complexity of signals, namely the Entropy, recently adopted to describe brain activity in physiopathological states, was evaluated to analyse local field potential data. Results showed that stroke mice had higher values of Entropy compared to healthy mice, indicating an increase in brain complexity and signal disorder due to the stroke. Additionally, the bihemispheric transcranial direct current stimulation reduced Entropy in both healthy and stroke mice compared to sham stimulated mice, with a greater effect in stroke mice. Moreover, correlation analysis showed a negative correlation between Entropy and Grip Strength values, indicating that higher Entropy values resulted in lower Grip Strength engagement. Concluding, the current evidence suggests that the Entropy index of brain complexity characterizes stroke pathology and recovery. Together with this, bihemispheric transcranial direct current stimulation can modulate brain rhythms in animal models of stroke, providing potentially new avenues for rehabilitation in humans.
Collapse
Affiliation(s)
- Francesca Miraglia
- Brain Connectivity Laboratory, Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele, 00163, Rome, Italy
- Department of Theoretical and Applied Sciences, eCampus University, Novedrate, 22060, Como, Italy
| | - Chiara Pappalettera
- Brain Connectivity Laboratory, Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele, 00163, Rome, Italy
- Department of Theoretical and Applied Sciences, eCampus University, Novedrate, 22060, Como, Italy
| | - Saviana Antonella Barbati
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
| | - Maria Vittoria Podda
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
| | - Claudio Grassi
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
| | - Paolo Maria Rossini
- Brain Connectivity Laboratory, Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele, 00163, Rome, Italy
| | - Fabrizio Vecchio
- Brain Connectivity Laboratory, Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele, 00163, Rome, Italy
- Department of Theoretical and Applied Sciences, eCampus University, Novedrate, 22060, Como, Italy
| |
Collapse
|
2
|
Yang X, Xu L, Zhao H, Xie T, Wang J, Wang L, Yang J. Curcumin protects against cerebral ischemia-reperfusion injury in rats by attenuating oxidative stress and inflammation: a meta-analysis and mechanism exploration. Nutr Res 2023; 113:14-28. [PMID: 36996692 DOI: 10.1016/j.nutres.2023.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2022] [Revised: 02/11/2023] [Accepted: 02/26/2023] [Indexed: 03/09/2023]
Abstract
Accumulating evidence has suggested that curcumin may protect against cerebral ischemia-reperfusion injury (CIRI). However, biological mechanisms vary across studies, limiting the clinical applicability of these findings. We performed a meta-analysis on publications evaluating curcumin administration in rat models of CIRI. Furthermore, we sought to test the hypothesis that curcumin alleviates CIRI through diminishing oxidation and inflammation. We searched PubMed, Embase, Web of Science, and Cochrane from the starting date of each database to May 2022 for experimental rat studies exploring the use of curcumin after ischemia reperfusion. Included articles were assessed for bias using SYRCLE's risk of bias tool. Data were aggregated by a random effects model. Curcumin administration significantly reduced neurological deficit score (20 studies; pooled mean difference [MD] = -1.57; 95% CI, -1.78 to -1.36, P < .00001), infarct volume (18 studies; pooled MD = -17.56%; 95% CI, -20.92% to -14.20%; P < 0.00001), and brain water content (8 studies, pooled MD = -11.29%, 95% CI: -16.48%, -6.11%, P < .00001). Compared with control, the levels of superoxide dismutase, glutathione, and glutathione peroxidase were significantly higher, whereas the levels of reactive oxygen species, malondialdehyde, interleukin-1β, interleukin-6, interleukin-8, and nuclear factor kappa B were significantly lower (P < .05). Subgroup analysis raised the possibility that intervention affections differed by curcumin's dose. To our knowledge, this is the first meta-analysis of curcumin's neuroprotection and mechanisms in rat CIRI models. Our analysis suggests the neuroprotective potential of curcumin in CIRI via antioxidant activity and anti-inflammatory effect. More research is required to further confirm the effectiveness and safety of curcumin on ischemic stroke therapy.
Collapse
Affiliation(s)
- Xuyi Yang
- School of Agriculture and Bioengineering, Taizhou Vocational College of Science and Technology, Taizhou, China
| | - Liang Xu
- School of Agriculture and Bioengineering, Taizhou Vocational College of Science and Technology, Taizhou, China
| | - Hui Zhao
- Department of Critical Care Medicine, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China
| | - Tinghui Xie
- School of Agriculture and Bioengineering, Taizhou Vocational College of Science and Technology, Taizhou, China
| | - Jiabing Wang
- Department of Pharmacy, Taizhou Municipal Hospital, Taizhou, China
| | - Lei Wang
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China
| | - Jianwei Yang
- General Practice, Zhejiang Taizhou Hospital, Linhai, China.
| |
Collapse
|
3
|
Tsai LC, Wu YN, Liu SQ, Zhang LQ. Changes in Muscle Stress and Sarcomere Adaptation in Mice Following Ischemic Stroke. Front Physiol 2020; 11:581846. [PMID: 33408638 PMCID: PMC7781356 DOI: 10.3389/fphys.2020.581846] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2020] [Accepted: 11/25/2020] [Indexed: 11/13/2022] Open
Abstract
While abnormal muscle tone has been observed in people with stroke, how these changes in muscle tension affect sarcomere morphology remains unclear. The purpose of this study was to examine time-course changes in passive muscle fiber tension and sarcomeric adaptation to these changes post-ischemic stroke in a mouse model by using a novel in-vivo force microscope. Twenty-one mice were evenly divided into three groups based on the time point of testing: 3 days (D3), 10 days (D10), and 20 days (D20) following right middle cerebral artery ligation. At each testing time, the muscle length, width, and estimated volume of the isolated soleus muscle were recorded, subsequently followed by in-vivo muscle tension and sarcomere length measurement. The mass of the soleus muscle was measured at the end of testing to calculate muscle density. Two-way ANOVA with repeated measures was used to examine the differences in each of the dependent variable among the three time-point groups and between the two legs. The passive muscle stress of the impaired limbs in the D3 group (27.65 ± 8.37 kPa) was significantly lower than the less involved limbs (42.03 ± 18.61 kPa; p = 0.05) and the impaired limbs of the D10 (48.92 ± 14.73; p = 0.03) and D20 (53.28 ± 20.54 kPa; p = 0.01) groups. The soleus muscle density of the impaired limbs in the D3 group (0.69 ± 0.12 g/cm3) was significantly lower than the less involved limbs (0.80 ± 0.09 g/cm3; p = 0.04) and the impaired limbs of the D10 (0.87 ± 0.12 g/cm3; p = 0.02) and D20 (1.00 ± 0.14 g/cm3; p < 0.01) groups. The D3 group had a shorter sarcomere length (2.55 ± 0.26 μm) than the D10 (2.83 ± 0.20 μm; p = 0.03) and D20 group (2.81 ± 0.15 μm; p = 0.04). These results suggest that, while ischemic stroke may cause considerable changes in muscle tension and stress, sarcomere additions under increased mechanical loadings may be absent or disrupted post-stroke, which may contribute to muscle spasticity and/or joint contracture commonly observed in patients following stroke.
Collapse
Affiliation(s)
- Liang-Ching Tsai
- Department of Physical Therapy, Georgia State University, Atlanta, GA, United States
| | - Yi-Ning Wu
- Department of Physical Therapy and Kinesiology, University of Massachusetts Lowell, Lowell, MA, United States
| | - Shu Q. Liu
- Department of Biomedical Engineering, Northwestern University, Evanston, IL, United States
| | - Li-Qun Zhang
- Department of Physical Therapy and Rehabilitation Science, University of Maryland, Baltimore, MD, United States
- Department of Orthopaedics, University of Maryland, Baltimore, MD, United States
- Department of Bioengineering, University of Maryland, College Park, MD, United States
| |
Collapse
|
4
|
CYP3A Excipient-Based Microemulsion Prolongs the Effect of Magnolol on Ischemia Stroke Rats. Pharmaceutics 2020; 12:pharmaceutics12080737. [PMID: 32764430 PMCID: PMC7464078 DOI: 10.3390/pharmaceutics12080737] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2020] [Revised: 07/29/2020] [Accepted: 08/04/2020] [Indexed: 12/14/2022] Open
Abstract
Magnolol, which is a CYP3A substrate, is a well-known agent that can facilitate neuroprotection and reduce ischemic brain damage. However, a well-controlled release formulation is needed for the effective delivery of magnolol due to its poor water solubility. In this study, we have developed a formulation for a CYP3A-excipient microemulsion, which can be administrated intraperitoneally to increase the solubility and bioavailability of magnolol and increase its neuroprotective effect against ischemic brain injury. The results showed a significant improvement in the area under the plotted curve of drug concentration versus time curve (AUC0–t) and mean residence time (MRT) of magnolol in microemulsion compared to when it was dissolved in dimethyl sulfoxide (DMSO). Both magnolol in DMSO and microemulsion, administrated after the onset of ischemia, showed a reduced visual brain infarct size. As such, this demonstrates a therapeutic effect on ischemic brain injury caused by occlusion, however it is important to note that a pharmacological effect cannot be concluded by this study. Ultimately, our study suggests that the excipient inhibitor-based microemulsion formulation could be a promising concept for the substrate drugs of CYP3A.
Collapse
|
5
|
Zhu T, Wang L, Tian F, Zhao X, Pu XP, Sun GB, Sun XB. Anti-ischemia/reperfusion injury effects of notoginsenoside R1 on small molecule metabolism in rat brain after ischemic stroke as visualized by MALDI-MS imaging. Biomed Pharmacother 2020; 129:110470. [PMID: 32768957 DOI: 10.1016/j.biopha.2020.110470] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2020] [Revised: 06/17/2020] [Accepted: 06/24/2020] [Indexed: 02/09/2023] Open
Abstract
Ischemic stroke is a syndrome of severe neurological responses that cause neuronal death, damage to the neurovascular unit and inflammation. Notoginsenoside R1 (NG-R1) is a neuroprotective drug that is commonly used to treat neurodegenerative and cerebrovascular diseases. However, its potential mechanisms on the regulation of small molecule metabolism in ischemic stroke are largely unknown. The aim of this study was to explore the potential mechanisms of NG-R1 on the regulation of small molecule metabolism after ischemic stroke. Here, we found that NG-R1 reduced infarct size and improved neurological deficits by ameliorating neuronal damage and inhibiting glial activation in MCAO/R rats. Furthermore, using matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI), we clarified that NG-R1 regulated ATP metabolism, the tricarboxylic acid (TCA) cycle, the malate-aspartate shuttle, antioxidant activity, and the homeostasis of iron and phospholipids in the striatum and hippocampus of middle cerebral artery occlusion/reperfusion (MCAO/R) rats. In general, NG-R1 is a promising compound for brain protection from ischemic/reperfusion injury, possibly through the regulation of brain small molecule metabolism.
Collapse
Affiliation(s)
- Ting Zhu
- Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100193, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China; Key Laboratory of New Drug Discovery Based on Classic Chinese Medicine Prescription, Chinese Academy of Medical Sciences, Beijing, 100193, China.
| | - Lei Wang
- Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100193, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China; Key Laboratory of New Drug Discovery Based on Classic Chinese Medicine Prescription, Chinese Academy of Medical Sciences, Beijing, 100193, China; Harbin University of Commerce, Harbin, Heilongjiang, 150000, China.
| | - Fang Tian
- National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, China.
| | - Xin Zhao
- National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, China.
| | - Xiao-Ping Pu
- National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, China.
| | - Gui-Bo Sun
- Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100193, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China; Key Laboratory of New Drug Discovery Based on Classic Chinese Medicine Prescription, Chinese Academy of Medical Sciences, Beijing, 100193, China.
| | - Xiao-Bo Sun
- Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100193, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China; Key Laboratory of New Drug Discovery Based on Classic Chinese Medicine Prescription, Chinese Academy of Medical Sciences, Beijing, 100193, China.
| |
Collapse
|
6
|
Das T, Soren K, Yerasi M, Kumar A, Chakravarty S. Revealing sex-specific molecular changes in hypoxia-ischemia induced neural damage and subsequent recovery using zebrafish model. Neurosci Lett 2019; 712:134492. [PMID: 31518677 DOI: 10.1016/j.neulet.2019.134492] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2019] [Revised: 08/25/2019] [Accepted: 09/09/2019] [Indexed: 12/20/2022]
Abstract
Functional recovery from hypoxia-ischemia depends on an individual's response to the ischemic damage and recovery. Many of the neurological disorders, including cerebral stroke have sex-specific characteristics. Deciphering the differential molecular mechanisms of sex-specific recovery from hypoxic-ischemic insult can improve medical practice in the treatment of cerebral stroke. In the present study, we describe the establishment of a sex-specific global hypoxia-ischemia neural damage and repair model in zebrafish. During hypoxic exposure a delayed behavioural response was observed in female fish that resumed normal swimming pattern earlier than their male counterparts. Moreover, female appeared more affected as they showed restricted locomotor and exploratory behaviour in novel tank test, reduced mitochondrial enzyme activity, enhanced DNA damage, and cell death after hypoxia insult. However, they showed a faster recovery as compared to male. Analysis of mRNA and protein expression levels of some characteristic hypoxic-ischemic markers showed notable sex-specific differences. Using zebrafish model, we have uncovered cellular and molecular differences in sex-specific systemic responses during the post-hypoxia recovery. This insight might help in devising better therapeutic strategy for stroke in female patients.
Collapse
Affiliation(s)
- Tapatee Das
- Applied Biology, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, U.P, India
| | - Kalyani Soren
- Applied Biology, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, U.P, India
| | - Mounica Yerasi
- Applied Biology, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad, India
| | - Arvind Kumar
- CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, U.P, India
| | - Sumana Chakravarty
- Applied Biology, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, U.P, India.
| |
Collapse
|
7
|
Wang H, Zhong D, Chen H, Jin J, Liu Q, Li G. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice. Life Sci 2019; 227:101-113. [DOI: 10.1016/j.lfs.2019.04.031] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2019] [Revised: 04/09/2019] [Accepted: 04/14/2019] [Indexed: 12/22/2022]
|
8
|
Functional importance of the TGF-β1/Smad3 signaling pathway in oxygen-glucose-deprived (OGD) microglia and rats with cerebral ischemia. Int J Biol Macromol 2018; 116:537-544. [DOI: 10.1016/j.ijbiomac.2018.04.113] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2018] [Revised: 04/18/2018] [Accepted: 04/22/2018] [Indexed: 11/20/2022]
|
9
|
Curcumin attenuates cerebral ischemia injury in Sprague–Dawley rats and PC12 cells by suppressing overactivated autophagy. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY 2018; 184:1-6. [DOI: 10.1016/j.jphotobiol.2018.05.010] [Citation(s) in RCA: 32] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/06/2018] [Revised: 04/30/2018] [Accepted: 05/06/2018] [Indexed: 12/22/2022]
|
10
|
Huang J, Wang T, Yu D, Fang X, Fan H, Liu Q, Yi G, Yi X, Liu Q. l-Homocarnosine attenuates inflammation in cerebral ischemia-reperfusion injury through inhibition of nod-like receptor protein 3 inflammasome. Int J Biol Macromol 2018; 118:357-364. [PMID: 29890246 DOI: 10.1016/j.ijbiomac.2018.06.032] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2018] [Revised: 06/06/2018] [Accepted: 06/07/2018] [Indexed: 10/14/2022]
Abstract
We investigated the therapeutic effects of l-homocarnosine against inflammation in a rat model of cerebral ischemia-reperfusion injury. Rats were grouped into control, middle cerebral artery occlusion (MCAO), 0.5 mM l-homocarnosine + MCAO, and 1 mM l-homocarnosine + MCAO treatment groups. Superoxide dismutase (SOD), glutathione peroxidase (Gpx), catalase, lipid peroxidation, and reduced glutathione (GSH) levels were measured. Neurological scores were assessed, and histopathology, scanning electron microscopy (SEM), and fluorescence microscopy analyses were conducted. The mRNA expression levels of nod-like receptor protein 3 (NLRP3), tumor necrosis factor alpha (TNF-α), and interleukin-6 (IL-6) and protein expression levels of NLRP3 were assessed. l-Homocarnosine supplementation substantially increased SOD, catalase, Gpx, and GSH levels, whereas it reduced the levels of lipid peroxidation relative to MCAO rats. l-Homocarnosine significantly reduced the infarct area and neurological deficit score, as well as histopathological alteration, apoptosis, and necrosis in brain tissue. The mRNA expression levels of NLRP3, TNF-α, and IL-6 were increased in MCAO rats, whereas l-homocarnosine supplementation reduced mRNA expression by >40%, and NLRP3 protein expression was reduced by >30% in 1 mM l-homocarnosine-treated MCAO rats. We propose that l-homocarnosine exerts a protective effect in cerebral ischemia-reperfusion injury-induced rats by downregulating NLRP3 expression.
Collapse
Affiliation(s)
- Jing Huang
- Department of Pharmacology, Hainan Medical University, Haikou, Hainan 571199, China
| | - Tao Wang
- International Nursing School, Hainan Medical University, Haikou, Hainan 571199, China
| | - Daorui Yu
- Department of Pharmacology, Hainan Medical University, Haikou, Hainan 571199, China
| | - Xingyue Fang
- Department of Pharmacology, Hainan Medical University, Haikou, Hainan 571199, China
| | - Haofei Fan
- Department of Pharmacology, Hainan Medical University, Haikou, Hainan 571199, China
| | - Qiang Liu
- Department of Pharmacology, Hainan Medical University, Haikou, Hainan 571199, China
| | - Guohui Yi
- Department of Pharmacology, Hainan Medical University, Haikou, Hainan 571199, China
| | - Xinan Yi
- Department of Anatomy, School of Basic Medicine and Life Science, Hainan Medical University, Haikou, Hainan 571199, China
| | - Qibing Liu
- Department of Pharmacology, Hainan Medical University, Haikou, Hainan 571199, China.
| |
Collapse
|
11
|
Li W, Liu H, Jiang H, Wang C, Guo Y, Sun Y, Zhao X, Xiong X, Zhang X, Zhang K, Nie Z, Pu X. (S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats. Sci Rep 2017; 7:10052. [PMID: 28855592 PMCID: PMC5577264 DOI: 10.1038/s41598-017-10283-4] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2017] [Accepted: 08/07/2017] [Indexed: 12/11/2022] Open
Abstract
Chronic cerebral hypoperfusion is a pathological state that is associated with the cognitive impairments in vascular dementia. Oxiracetam is a nootropic drug that is commonly used to treat cognitive deficits of cerebrovascular origins. However, oxiracetam is currently used as a racemic mixture whose effective ingredient has not been identified to date. In this study, we first identified that (S)-oxiracetam, but not (R)-oxiracetam, was the effective ingredient that alleviated the impairments of spatial learning and memory by ameliorating neuron damage and white matter lesions, increasing the cerebral blood flow, and inhibiting astrocyte activation in chronic cerebral hypoperfused rats. Furthermore, using MALDI-MSI and LC-MS/MS, we demonstrated that (S)-oxiracetam regulated ATP metabolism, glutamine-glutamate and anti-oxidants in the cortex region of hypoperfused rats. Altogether, our results strongly suggest that (S)-oxiracetam alone could be a nootropic drug for the treatment of cognitive impairments caused by cerebral hypoperfusion.
Collapse
Affiliation(s)
- Wan Li
- National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, P. R. China.,Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, P. R. China
| | - Huihui Liu
- Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, P. R. China
| | - Hanjie Jiang
- National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, P. R. China.,Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, P. R. China
| | - Chen Wang
- National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, P. R. China.,Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, P. R. China
| | - Yongfei Guo
- National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, P. R. China.,Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, P. R. China
| | - Yi Sun
- National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, P. R. China.,Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, P. R. China
| | - Xin Zhao
- National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, P. R. China.,Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, P. R. China
| | - Xin Xiong
- Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, P. R. China
| | - Xianhua Zhang
- Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, P. R. China
| | - Ke Zhang
- National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, P. R. China.,Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, P. R. China
| | - Zongxiu Nie
- Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, P. R. China.
| | - Xiaoping Pu
- National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, P. R. China. .,Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, P. R. China.
| |
Collapse
|
12
|
Li W, Suwanwela NC, Patumraj S. Curcumin prevents reperfusion injury following ischemic stroke in rats via inhibition of NF‑κB, ICAM-1, MMP-9 and caspase-3 expression. Mol Med Rep 2017; 16:4710-4720. [PMID: 28849007 PMCID: PMC5647023 DOI: 10.3892/mmr.2017.7205] [Citation(s) in RCA: 59] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2016] [Accepted: 06/06/2017] [Indexed: 12/21/2022] Open
Abstract
Reperfusion is the only approved therapy for acute ischemic stroke; however, it can cause excessive inflammation responses and aggravate brain damage. Therefore, supplementary treatment against inflammation caused by reperfusion is required. In a previous study from our group, curcumin was demonstrated to decrease infarction volume, brain edema and blood-brain barrier (BBB) disruption against cerebral ischemia/reperfusion (I/R) injury. However, the underlying mechanisms remain unclear. The present study was conducted to understand whether curcumin protects against cerebral I/R injury through anti-inflammatory and antiapoptotic properties. Ischemia for 1 h was induced in vivo in Wistar rats by middle cerebral artery occlusion (MCAO), followed by reperfusion for 24 h, and curcumin was injected intraperitoneally at 30 min prior to reperfusion. Immunohistochemistry was performed to analyze the expression levels of nuclear factor (NF)-κB, intercellular adhesion molecule (ICAM)-1, matrix metalloproteinase (MMP)-9 and caspase-3. The findings revealed that inflammation (NF-κB, ICAM-1 and MMP-9) and apoptosis (caspase-3)-related markers were significantly downregulated in the curcumin-treated MCAO group compared with the vehicle-treated MCAO group. Furthermore, brain infarction size, brain edema and neurological dysfunction were attenuated in the curcumin-treated MCAO group compared with the vehicle-treated MCAO group. Taken together, the present results provided evidence that the protective effect of curcumin against cerebral I/R injury might be mediated by anti-inflammatory and anti-apoptotic properties. Therefore, curcumin may be a promising supplementary agent against cerebral I/R injury in the future.
Collapse
Affiliation(s)
- Wei Li
- Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
| | - Nijasri Charnnarong Suwanwela
- Division of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
| | - Suthiluk Patumraj
- Center of Excellence for Microcirculation, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
| |
Collapse
|
13
|
Kim DE, Kim JY, Schellingerhout D, Ryu JH, Lee SK, Jeon S, Lee JS, Kim J, Jang HJ, Park JE, Kim EJ, Kwon IC, Ahn CH, Nahrendorf M, Kim K. Quantitative Imaging of Cerebral Thromboemboli In Vivo. Stroke 2017; 48:1376-1385. [DOI: 10.1161/strokeaha.117.016511] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2017] [Revised: 02/01/2017] [Accepted: 02/09/2017] [Indexed: 01/21/2023]
Abstract
Background and Purpose—
Quantitative imaging for the noninvasive assessment of thrombolysis is needed to advance basic and clinical thrombosis-related research and tailor tissue-type plasminogen activator (tPA) treatment for stroke patients. We quantified the evolution of cerebral thromboemboli using fibrin-targeted glycol chitosan–coated gold nanoparticles and microcomputed tomography, with/without tPA therapy.
Methods—
We injected thrombi into the distal internal carotid artery in mice (n=50). Fifty-five minutes later, we injected fibrin-targeted glycol chitosan–coated gold nanoparticles, and 5 minutes after that, we treated animals with tPA or not (25 mg/kg). We acquired serial microcomputed tomography images for 24 hours posttreatment.
Results—
Thrombus burden at baseline was 784×10
3
±59×10
3
μm
2
for the tPA group (n=42) and 655×10
3
±103×10
3
μm
2
for the saline group (n=8;
P
=0.37). Thrombus shrinkage began at 0.5 to 1 hour after tPA therapy, with a maximum initial rate of change at 4603±957 μm
2
/min. The rate of change lowered to ≈61% level of the initial in hours 1 to 2, followed by ≈29% and ≈1% in hours 2 to 3 and 3 to 24, respectively. Thus, 85% of total thrombolysis over 24 hours (≈500 μm
2
, equivalent to 64% of the baseline thrombus burden) occurred within the first 3 hours of treatment. Thrombus burden at 24 hours could be predicted at around 1.5 to 2 hours. Saline treatment was not associated with significant changes in the thrombus burden. Infarct size was smaller in the tPA group versus saline group (18.1±2.3 versus 45.8±3.3 mm
2
;
P
<0.01). Infarct size correlated to final thrombus burden (
r
=0.71;
P
<0.01). Time to thrombolysis, completeness of thrombolysis, and tPA therapy were independent predictors of infarct size.
Conclusions—
Thromboembolic burden and the efficacy of tPA therapy can be assessed serially, noninvasively, and quantitatively using high-resolution microcomputed tomography and a fibrin-binding nanoparticle imaging agent.
Collapse
Affiliation(s)
- Dong-Eog Kim
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Jeong-Yeon Kim
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Dawid Schellingerhout
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Ju Hee Ryu
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Su-Kyoung Lee
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Sangmin Jeon
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Ji Sung Lee
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Jiwon Kim
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Hee Jeong Jang
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Jung E. Park
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Eo Jin Kim
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Ick Chan Kwon
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Cheol-Hee Ahn
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Matthias Nahrendorf
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| | - Kwangmeyung Kim
- From Molecular Imaging and Neurovascular Research Laboratory, Departments of Neurology (D.-E.K., J.-Y.K., S.-K.L., J.K., H.J.J., J.E.P.) and Pathology (E.J.K.), Dongguk University College of Medicine, Goyang, South Korea; Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea (J.H.R., S.J., I.C.K., K.K.); Departments of Diagnostic Radiology and Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston (D.S.); Clinical Research Center, Asan
| |
Collapse
|
14
|
Activation of NLRP3 inflammasome by cholesterol crystals in alcohol consumption induces atherosclerotic lesions. Brain Behav Immun 2017; 62:291-305. [PMID: 28232172 PMCID: PMC6378699 DOI: 10.1016/j.bbi.2017.02.014] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/22/2016] [Revised: 02/17/2017] [Accepted: 02/18/2017] [Indexed: 10/20/2022] Open
Abstract
Epidemiological studies showed a strong association between alcoholism and incidence of stroke, for which the underlying causative mechanisms remain to be understood. Here we found that infiltration of immune cells and deposition of cholesterol at the site of brain artery/capillary injury induced atherosclerosis in chronic alcohol (ethanol) consumption in the presence or absence of high-fat diet. Conversion of cholesterol into sharp edges of cholesterol crystals (CCs) in alcohol intake was key to activation of NLRP3 inflammasome, induction of cerebral atherosclerosis, and development of neuropathy around the atherosclerotic lesions. The presence of alcohol was critical for the formation of CCs and development of the neuropathology. Thus, we observed that alcohol consumption elevated the level of plasma cholesterol, deposition and crystallization of cholesterol, as well as activation of NLRP3 inflammasome. This led to arteriole or capillary walls thickening and increase intracranial blood pressure. Distinct neuropathy around the atherosclerotic lesions indicated vascular inflammation as an initial cause of neuronal degeneration. We demonstrated the molecular mechanisms of NLRP3 activation and downstream signaling cascade event in primary culture of human brain arterial/capillary endothelial cells in the setting of dose-/time-dependent effects of alcohol/CCs using NLRP3 gene silencing technique. We also detected CCs in blood samples from alcohol users, which validated the clinical importance of the findings. Finally, combined therapy of acetyl-l-carnitine and Lipitor® prevented deposition of cholesterol, formation of CCs, activation of NLRP3, thickening of vessel walls, and elevation of intracranial blood pressure. We conclude that alcohol-induced accumulation and crystallization of cholesterol activates NLRP3/caspase-1 in the cerebral vessel that leads to early development of atherosclerosis.
Collapse
|
15
|
Li W, Suwanwela NC, Patumraj S. Curcumin by down-regulating NF-kB and elevating Nrf2, reduces brain edema and neurological dysfunction after cerebral I/R. Microvasc Res 2015; 106:117-27. [PMID: 26686249 DOI: 10.1016/j.mvr.2015.12.008] [Citation(s) in RCA: 111] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2015] [Revised: 12/09/2015] [Accepted: 12/09/2015] [Indexed: 10/22/2022]
Abstract
BACKGROUND Oxidation, inflammation, and apoptosis are three critical factors for the pathogenic mechanism of cerebral ischemia/reperfusion (I/R) injury. Curcumin exhibits substantial biological properties via anti-oxidation, anti-inflammation and anti-apoptotic effects; however, the molecular mechanism underlying the effects of curcumin against cerebral I/R injury remains unclear. OBJECTIVE To investigate the effects of curcumin on cerebral I/R injury associated with water content, infarction volume, and the expression of nuclear factor-kappa-B (NF-κB) and nuclear factor-erythroid-related factor-2 (Nrf2). METHODS Middle cerebral artery occlusion (MCAO, 1-hour occlusion and 24-hour reperfusion) was performed in male Wistar rats (n=64) as a cerebral I/R injury model. In the MCAO+CUR group, the rats were administered curcumin (300mg/kg BW, i.p.) at 30min after occlusion. The same surgical procedures were performed in SHAM rats without MCAO occlusion. At 24h post-operation, the parameters, including neurological deficit scores, blood brain barrier (BBB) disruption, water content, and infarction volume, were determined. Brain tissue NF-κB and Nrf2 expression levels were assayed through immunohistochemistry. RESULTS Compared with the SHAM group, BBB disruption, neurological deficit, and increased brain water content and infarction volume were markedly demonstrated in the MCAO group. NF-κB expression was enhanced in the MCAO group. However, in the MCAO+CUR group, the upregulation of Nrf2, an anti-oxidation related protein, was consistent with a significant decline in the water content, infarction volume, and NF-κB expression. CONCLUSION The protective effects of curcumin against cerebral I/R injury reflect anti-oxidation, anti-inflammation and anti-apoptotic activities, resulting in the elevation of Nrf2 and down-regulation of NF-κB.
Collapse
Affiliation(s)
- Wei Li
- International Ph.D. Program in Medical Science, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand
| | - Nijasri C Suwanwela
- Division of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand
| | - Suthiluk Patumraj
- Center of Excellence for Microcirculation, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.
| |
Collapse
|
16
|
Lee KC, Yu JF, Lee YS, Huang GJ, Chan HL, Lin IT, Chen JH. In Vivo Sodium MRI for Mouse Model of Ischemic Stroke at 7 T: Preliminary Results. J Med Biol Eng 2015. [DOI: 10.1007/s40846-015-0072-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
17
|
Gao Y, Goodnough CL, Erokwu BO, Farr GW, Darrah R, Lu L, Dell KM, Yu X, Flask CA. Arterial spin labeling-fast imaging with steady-state free precession (ASL-FISP): a rapid and quantitative perfusion technique for high-field MRI. NMR IN BIOMEDICINE 2014; 27:996-1004. [PMID: 24891124 PMCID: PMC4110188 DOI: 10.1002/nbm.3143] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/09/2013] [Revised: 04/28/2014] [Accepted: 04/30/2014] [Indexed: 05/03/2023]
Abstract
Arterial spin labeling (ASL) is a valuable non-contrast perfusion MRI technique with numerous clinical applications. Many previous ASL MRI studies have utilized either echo-planar imaging (EPI) or true fast imaging with steady-state free precession (true FISP) readouts, which are prone to off-resonance artifacts on high-field MRI scanners. We have developed a rapid ASL-FISP MRI acquisition for high-field preclinical MRI scanners providing perfusion-weighted images with little or no artifacts in less than 2 s. In this initial implementation, a flow-sensitive alternating inversion recovery (FAIR) ASL preparation was combined with a rapid, centrically encoded FISP readout. Validation studies on healthy C57/BL6 mice provided consistent estimation of in vivo mouse brain perfusion at 7 and 9.4 T (249 ± 38 and 241 ± 17 mL/min/100 g, respectively). The utility of this method was further demonstrated in the detection of significant perfusion deficits in a C57/BL6 mouse model of ischemic stroke. Reasonable kidney perfusion estimates were also obtained for a healthy C57/BL6 mouse exhibiting differential perfusion in the renal cortex and medulla. Overall, the ASL-FISP technique provides a rapid and quantitative in vivo assessment of tissue perfusion for high-field MRI scanners with minimal image artifacts.
Collapse
Affiliation(s)
- Ying Gao
- Department of Radiology, Case Western Reserve University, Cleveland, OH 44106
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106
| | - Candida L. Goodnough
- Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106
| | | | - George W. Farr
- Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106
- Aeromics, LLC, Cleveland, OH 44106
| | - Rebecca Darrah
- Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH 44106
- Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH 44106
| | - Lan Lu
- Department of Radiology, Case Western Reserve University, Cleveland, OH 44106
- Department of Urology, Case Western Reserve University, Cleveland, OH 44106
| | - Katherine M. Dell
- CWRU Center for the Study of Kidney Disease and Biology, MetroHealth Campus, Case Western Reserve University, Cleveland, OH 44109
- Department of Pediatrics, Case Western Reserve University, Cleveland, OH 44106
| | - Xin Yu
- Department of Radiology, Case Western Reserve University, Cleveland, OH 44106
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106
- Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106
| | - Chris A. Flask
- Department of Radiology, Case Western Reserve University, Cleveland, OH 44106
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106
- Department of Pediatrics, Case Western Reserve University, Cleveland, OH 44106
| |
Collapse
|
18
|
Batchelor PE, Wills TE, Skeers P, Battistuzzo CR, Macleod MR, Howells DW, Sena ES. Meta-analysis of pre-clinical studies of early decompression in acute spinal cord injury: a battle of time and pressure. PLoS One 2013; 8:e72659. [PMID: 24009695 PMCID: PMC3751840 DOI: 10.1371/journal.pone.0072659] [Citation(s) in RCA: 69] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2013] [Accepted: 07/12/2013] [Indexed: 12/05/2022] Open
Abstract
Background The use of early decompression in the management of acute spinal cord injury (SCI) remains contentious despite many pre-clinical studies demonstrating benefits and a small number of supportive clinical studies. Although the pre-clinical literature favours the concept of early decompression, translation is hindered by uncertainties regarding overall treatment efficacy and timing of decompression. Methods We performed meta-analysis to examine the pre-clinical literature on acute decompression of the injured spinal cord. Three databases were utilised; PubMed, ISI Web of Science and Embase. Our inclusion criteria consisted of (i) the reporting of efficacy of decompression at various time intervals (ii) number of animals and (iii) the mean outcome and variance in each group. Random effects meta-analysis was used and the impact of study design characteristics assessed with meta-regression. Results Overall, decompression improved behavioural outcome by 35.1% (95%CI 27.4-42.8; I2=94%, p<0.001). Measures to minimise bias were not routinely reported with blinding associated with a smaller but still significant benefit. Publication bias likely also contributed to an overestimation of efficacy. Meta-regression demonstrated a number of factors affecting outcome, notably compressive pressure and duration (adjusted r2=0.204, p<0.002), with increased pressure and longer durations of compression associated with smaller treatment effects. Plotting the compressive pressure against the duration of compression resulting in paraplegia in individual studies revealed a power law relationship; high compressive forces quickly resulted in paraplegia, while low compressive forces accompanying canal narrowing resulted in paresis over many hours. Conclusion These data suggest early decompression improves neurobehavioural deficits in animal models of SCI. Although much of the literature had limited internal validity, benefit was maintained across high quality studies. The close relationship of compressive pressure to the rate of development of severe neurological injury suggests that pressure local to the site of injury might be a useful parameter determining the urgency of decompression.
Collapse
Affiliation(s)
- Peter E. Batchelor
- Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia
- Department of Medicine, University of Melbourne, Heidelberg, Victoria, Australia
- * E-mail:
| | - Taryn E. Wills
- Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia
- Department of Medicine, University of Melbourne, Heidelberg, Victoria, Australia
| | - Peta Skeers
- Department of Medicine, University of Melbourne, Heidelberg, Victoria, Australia
| | | | - Malcolm R. Macleod
- Division of Clinical Neurosciences, University of Edinburgh, Edinburgh, United Kingdom
| | - David W. Howells
- Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia
| | - Emily S. Sena
- Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia
- Division of Clinical Neurosciences, University of Edinburgh, Edinburgh, United Kingdom
| |
Collapse
|
19
|
Cerebral blood volume affects blood-brain barrier integrity in an acute transient stroke model. J Cereb Blood Flow Metab 2013; 33:898-905. [PMID: 23462571 PMCID: PMC3677109 DOI: 10.1038/jcbfm.2013.27] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Insufficient vascular reserve after an ischemic stroke may induce biochemical cascades that subsequently deteriorate the blood-brain barrier (BBB) function. However, the direct relationship between poor cerebral blood volume (CBV) restoration and BBB disruption has not been examined in acute stroke. To quantify BBB integrity at acute stages of transient stroke, in particular for cases in which extravasation of the standard contrast agent (Gd-DTPA) is not observed, we adopted the water exchange index (WEI), a novel magnetic resonance image-derived parameter to estimate the water permeability across the BBB. The apparent diffusion coefficient (ADC) and R2 relaxation rate constant were also measured for outlining the tissue abnormality, while fractional CBV and WEI were quantified for assessing vascular alterations. The significantly decreased ADC and R2 in the ischemic cortices did not correlate with the changes in CBV or WEI. In contrast, a strong negative correlation between the ipsilesional WEI and CBV was found, in which stroke mice were clustered into two groups: (1) high WEI and low CBV and (2) normal WEI and CBV. The low CBV observed for mice with a disrupted BBB, characterized by a high WEI, indicates the importance of CBV restoration for maintaining BBB stability in acute stroke.
Collapse
|
20
|
Sousa LFDC, Coelho FM, Rodrigues DH, Campos AC, Barcelos LDS, Teixeira MM, Rachid MA, Teixeira AL. Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice. Clinics (Sao Paulo) 2013; 68:391-4. [PMID: 23644861 PMCID: PMC3611745 DOI: 10.6061/clinics/2013(03)oa17] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/12/2012] [Accepted: 11/22/2012] [Indexed: 01/17/2023] Open
Abstract
OBJECTIVE Ischemic stroke may result from transient or permanent reductions of regional cerebral blood flow. Polymorphonuclear neutrophils have been described as the earliest inflammatory cells to arrive in ischemic tissue. CXCR1/2 receptors are involved in the recruitment of these cells. However, the contribution of these chemokine receptors during transient brain ischemia in mice remains poorly understood. In this work, we investigated the effects of reparixin, an allosteric antagonist of CXCR1/2 receptors, in a model of middle cerebral artery occlusion and reperfusion in mice. METHODS C57BL/6J male mice treated with reparixin or vehicle were subjected to a middle cerebral artery occlusion procedure 1 h after the treatment. Ninety minutes after ischemia induction, the monofilament that prevented blood flow was removed. Twenty-four hours after the reperfusion procedure, behavioral changes, including motor signs, were analyzed with the SmithKline/Harwell/lmperial College/Royal Hospital/Phenotype Assessment (SHIRPA) battery. The animals were sacrificed, and brain tissue was removed for histological and biochemical analyses. Histological sections were stained with hematoxylin and eosin, neutrophil infiltration was estimated by myeloperoxidase activity and the inflammatory cytokine IL-iβ was measured by ELISA. RESULTS Pre-treatment with reparixin reduced the motor deficits observed in this model of ischemia and reperfusion. Myeloperoxidase activity and IL-iβ were reduced in the reparixin-treated group. Histological analysis revealed that ischemic injury was also attenuated by reparixin pre-treatment. CONCLUSIONS Our results suggest that the blockade of the CXCR1/2 receptors by reparixin promotes neuroprotective effects by reducing the levels of polymorphonuclear infiltration in the brain and the tissue damage associated with middle cerebral artery occlusion and reperfusion.
Collapse
Affiliation(s)
- Larissa Fonseca da Cunha Sousa
- Departamento de Bioqufmica e Imunologia, Laboratorio de Imunofarmacologia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Armogida M, Nisticò R, Mercuri NB. Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia. Br J Pharmacol 2012; 166:1211-24. [PMID: 22352897 DOI: 10.1111/j.1476-5381.2012.01912.x] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
For many years after its discovery, hydrogen peroxide (H₂O₂) was viewed as a toxic molecule to human tissues; however, in light of recent findings, it is being recognized as an ubiquitous endogenous molecule of life as its biological role has been better elucidated. Indeed, increasing evidence suggests that H₂O₂ may act as a second messenger with a pro-survival role in several physiological processes. In addition, our group has recently demonstrated neuroprotective effects of H₂O₂ on in vitro and in vivo ischaemic models through a catalase (CAT) enzyme-mediated mechanism. Therefore, the present review summarizes experimental data supporting a neuroprotective potential of H₂O₂ in ischaemic stroke that has been principally achieved by means of pharmacological and genetic strategies that modify either the activity or the expression of the superoxide dismutase (SOD), glutathione peroxidase (GPx) and CAT enzymes, which are key regulators of H₂O₂ metabolism. It also critically discusses a translational impact concerning the role played by H₂O₂ in ischaemic stroke. Based on these data, we hope that further research will be done in order to better understand the mechanisms underlying H₂O₂ functions and to promote successful H₂O₂ signalling based therapy in ischaemic stroke.
Collapse
Affiliation(s)
- Marta Armogida
- Laboratory of Experimental Neurology, Fondazione Santa Lucia IRCCS, Rome, Italy
| | | | | |
Collapse
|
22
|
Perasso L, Spallarossa P, Gandolfo C, Ruggeri P, Balestrino M. Therapeutic Use of Creatine in Brain or Heart Ischemia: Available Data and Future Perspectives. Med Res Rev 2011; 33:336-63. [DOI: 10.1002/med.20255] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Luisa Perasso
- Department of Neuroscience, Opthalmology and Genetics; University of Genova; Genova Italy
- Department of Experimental Medicine, Section of Human Physiology; University of Genova; Genova Italy
| | - Paolo Spallarossa
- Department of Internal Medicine and Cardionephrology; University of Genova; Genova Italy
| | - Carlo Gandolfo
- Department of Neuroscience, Opthalmology and Genetics; University of Genova; Genova Italy
| | - Piero Ruggeri
- Department of Experimental Medicine, Section of Human Physiology; University of Genova; Genova Italy
| | - Maurizio Balestrino
- Department of Neuroscience, Opthalmology and Genetics; University of Genova; Genova Italy
| |
Collapse
|
23
|
Lagace DC. Does the endogenous neurogenic response alter behavioral recovery following stroke? Behav Brain Res 2011; 227:426-32. [PMID: 21907736 DOI: 10.1016/j.bbr.2011.08.045] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2011] [Revised: 08/26/2011] [Accepted: 08/29/2011] [Indexed: 12/22/2022]
Abstract
In response to stroke, the adult brain has the remarkable ability to enhance the proliferation of new cells, which form new neurons in restricted regions. This review focuses on studies that have directly tested the hypothesis that neurogenesis contributes to post-stroke behavioral recovery. The translational potential of this area of research is critically assessed with respect to the selection of appropriate stroke models, subjects, neurogenic regions examined, behavioral tests used, and experimental timecourse. Building upon those studies that suggest an association between endogeneous neurogenesis and improved stroke recovery, we are nonetheless left with the challenge to demonstrate a causal link between neurogenesis and behavioral recovery using new technology.
Collapse
Affiliation(s)
- Diane C Lagace
- Department of Cellular and Molecular Medicine, University of Ottawa, Ontario, Canada.
| |
Collapse
|
24
|
Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener 2011; 6:11. [PMID: 21266064 PMCID: PMC3037909 DOI: 10.1186/1750-1326-6-11] [Citation(s) in RCA: 363] [Impact Index Per Article: 27.9] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2010] [Accepted: 01/25/2011] [Indexed: 01/02/2023] Open
Abstract
Stroke is the world's second leading cause of mortality, with a high incidence of severe morbidity in surviving victims. There are currently relatively few treatment options available to minimize tissue death following a stroke. As such, there is a pressing need to explore, at a molecular, cellular, tissue, and whole body level, the mechanisms leading to damage and death of CNS tissue following an ischemic brain event. This review explores the etiology and pathogenesis of ischemic stroke, and provides a general model of such. The pathophysiology of cerebral ischemic injury is explained, and experimental animal models of global and focal ischemic stroke, and in vitro cellular stroke models, are described in detail along with experimental strategies to analyze the injuries. In particular, the technical aspects of these stroke models are assessed and critically evaluated, along with detailed descriptions of the current best-practice murine models of ischemic stroke. Finally, we review preclinical studies using different strategies in experimental models, followed by an evaluation of results of recent, and failed attempts of neuroprotection in human clinical trials. We also explore new and emerging approaches for the prevention and treatment of stroke. In this regard, we note that single-target drug therapies for stroke therapy, have thus far universally failed in clinical trials. The need to investigate new targets for stroke treatments, which have pleiotropic therapeutic effects in the brain, is explored as an alternate strategy, and some such possible targets are elaborated. Developing therapeutic treatments for ischemic stroke is an intrinsically difficult endeavour. The heterogeneity of the causes, the anatomical complexity of the brain, and the practicalities of the victim receiving both timely and effective treatment, conspire against developing effective drug therapies. This should in no way be a disincentive to research, but instead, a clarion call to intensify efforts to ameliorate suffering and death from this common health catastrophe. This review aims to summarize both the present experimental and clinical state-of-the art, and to guide future research directions.
Collapse
Affiliation(s)
- Trent M Woodruff
- School of Biomedical Sciences, University of Queensland, Brisbane, Queensland 4072, Australia.
| | | | | | | | | | | |
Collapse
|
25
|
Batchelor PE, Kerr NF, Gatt AM, Aleksoska E, Cox SF, Ghasem-Zadeh A, Wills TE, Howells DW. Hypothermia Prior to Decompression: Buying Time for Treatment of Acute Spinal Cord Injury. J Neurotrauma 2010; 27:1357-68. [DOI: 10.1089/neu.2010.1360] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Affiliation(s)
- Peter E. Batchelor
- National Stroke Research Institute and University of Melbourne, Department of Medicine, Heidelberg, Victoria, Australia
| | - Nicole F. Kerr
- National Stroke Research Institute and University of Melbourne, Department of Medicine, Heidelberg, Victoria, Australia
| | - Amy M. Gatt
- National Stroke Research Institute and University of Melbourne, Department of Medicine, Heidelberg, Victoria, Australia
| | - Elena Aleksoska
- National Stroke Research Institute and University of Melbourne, Department of Medicine, Heidelberg, Victoria, Australia
| | - Susan F. Cox
- National Stroke Research Institute and University of Melbourne, Department of Medicine, Heidelberg, Victoria, Australia
| | - Ali Ghasem-Zadeh
- Endocrinology Centre of Excellence, Austin Health, Heidelberg, Victoria, Australia
| | - Taryn E. Wills
- National Stroke Research Institute and University of Melbourne, Department of Medicine, Heidelberg, Victoria, Australia
| | - David W. Howells
- National Stroke Research Institute and University of Melbourne, Department of Medicine, Heidelberg, Victoria, Australia
| |
Collapse
|